Credo Therapies is a startup based in the United Kingdom, most recent round Series-c-plus, 1 tracked investor.
Credo Therapies is a company founded in 2018 headquartered in the United Kingdom. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Credo Therapies delivers digitised psychotherapy for non-restrictive eating disorders through a clinically validated, tech-enabled platform built on Oxford university research.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.